首页> 美国卫生研究院文献>Journal of Family Reproductive Health >Comparing the Efficiency of Three Protocols in Isolation of Cell Free Fetal DNA From Maternal Blood
【2h】

Comparing the Efficiency of Three Protocols in Isolation of Cell Free Fetal DNA From Maternal Blood

机译:比较三种方案从母体血液中分离无细胞胎儿DNA的效率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objective: Recent advances in non-invasive prenatal diagnosis (NIPD) through cell free fetal DNA (cffDNA) has highlighted cffDNA purification as a critical initial step. Herein, we aimed to compare the efficiency of one proposed protocol with two commercial kits for isolation of cffDNA. >Materials and methods: cffDNA was isolated from whole blood of 50 normal pregnancies using one proposed manual protocol compared with QIAamp DNA Blood Mini and s. Methylated DNA immunoprecipitation real time polymerase chain reaction (MeDIP-Real time PCR) was performed to quantify three fetal specific sequences. >Results: Maximum cffDNA quantity was obtained by suggested protocol (248.79 ± 14.07 ng/µl) and the best quality was achieved by Bioneer Kit (OD ratio: 260/280 nmm: 1.69 ± 0.09, 260/230 nmm: 1.15 ± 0.13) (p < 0.001). Enrichment of fetal specific sequences was significantly higher when proposed protocol was used to isolate cffDNA (p = 0.01). >Conclusion: Inhibitory effect of NaI on nucleases and double digestion of DNA associated proteins may be the main reasons behind the superiority of suggested protocol. Significantly higher amplification of fetal specific sequences in suggested protocol would be a strong evidence on recovery of small fetal fragments as demonstrated with its maximum total DNA quantity and amplification in different PCR reactions.
机译:>目的:通过无细胞胎儿DNA(cffDNA)进行的非侵入性产前诊断(NIPD)的最新进展突显了cffDNA纯化是关键的第一步。在本文中,我们旨在比较一种提议的方案与两种用于分离cffDNA的商业试剂盒的效率。 >材料和方法:与QIAamp DNA Blood Mini和s相比,使用一种拟议的人工操作方案从50例正常妊娠的全血中分离出cffDNA。进行了甲基化的DNA免疫沉淀实时聚合酶链反应(MeDIP-实时PCR),以定量三个胎儿特异性序列。 >结果:通过建议的方案获得了最大的cffDNA量(248.79±14.07 ng / µl),并且通过Bioneer Kit获得了最佳的质量(OD比:260/280 nm / nm:1.69±0.09,260 / 230 nm / nm:1.15±0.13)(p <0.001)。当使用建议的方案分离cffDNA时,胎儿特异性序列的富集度显着更高(p = 0.01)。 >结论: NaI对核酸酶的抑制作用和DNA相关蛋白的双重消化可能是建议方案优越的主要原因。建议的方案中胎儿特异性序列的显着更高的扩增将是小胎儿片段回收的有力证据,如其最大总DNA量和在不同PCR反应中的扩增所证明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号